Muscle-specific programmed cell death 5 deletion attenuates cardiac aging

Area of Science:

• Cardiovascular Biology
• Aging Research
• Molecular Biology

Background:

• Programmed cell death 5 (PDCD5) is a known tumor suppressor gene.
• The role of PDCD5 in cardiac aging is currently unknown.
• PDCD5 levels increase in the aging heart.

Purpose of the Study:

• To investigate the physiological function of PDCD5 in cardiac aging.
• To determine if PDCD5 regulates age-related cardiac dysfunction.
• To explore PDCD5 as a potential therapeutic target for cardiac aging.

Main Methods:

• Generated muscle-specific PDCD5-deficient mice.
• Assessed cardiac morphology and function in aged and young mice.
• Analyzed cellular senescence markers, apoptosis, and mitochondrial quality (mitophagy).
• Investigated the interaction between PDCD5 and p53.

Main Results:

• PDCD5 deficiency attenuated age-related cardiac fibrosis and cardiomyocyte hypertrophy.
• Reduced cellular senescence, apoptosis, and improved mitochondrial quality in aged hearts.
• PDCD5 deficiency protected against doxorubicin-induced premature cardiac aging.
• PDCD5 interacted with p53, suggesting a role in its regulation.

Conclusions:

• PDCD5 deficiency attenuates cardiac aging by reducing cellular senescence and apoptosis.
• Increased Parkin-mediated mitophagy and p53 interaction are key mechanisms.
• PDCD5 is a novel regulator of cardiac aging and a potential therapeutic target.